Skip to content
Review Open access

EXOSOMES - BASED DRUG DELIVERY SYSTEMS: EMERGING OPPORTUNITIES FOR TARGETED THERAPEUTICS AND PRECISION MEDICINE

May 2026 · The Bioscan · 0 citations · 7 references

TL;DR

This review highlights the biological characteristics, biogenesis, sources, isolation, purification, and characterization techniques of exosomes, and summarizes the applications of exosome-based drug delivery in cancer, neurological disorders, cardiovascular diseases,inflammatory conditions, infectious diseases, regenerative medicine, and gene therapy.

Abstract

Exosome-based drug delivery systems have emerged as a promising platform for targeted therapeuticsand precision medicine because of their excellent biocompatibility, low immunogenicity, and intrinsicability to transport diverse therapeutic molecules. Unlike conventional nanocarriers, exosomesefficiently deliver proteins, nucleic acids, and small-molecule drugs while overcoming biologicalbarriers, including the blood–brain barrier. This review highlights the biological characteristics,biogenesis, sources, isolation, purification, and characterization techniques of exosomes. It alsodiscusses recent advances in drug-loading strategies, surface engineering, and exosome modification toimprove targeting efficiency and therapeutic performance. Furthermore, the review summarizes theapplications of exosome-based drug delivery in cancer, neurological disorders, cardiovascular diseases,inflammatory conditions, infectious diseases, regenerative medicine, and gene therapy. Despite theirremarkable therapeutic potential, challenges related to large-scale production, standardization, storagestability, and regulatory approval remain significant barriers to clinical translation. Continued researchand technological advancements are expected to facilitate the successful integration of exosome-basedtherapeutics into personalized healthcare.

Read PDF

Similar papers

Review Open access Jul 2026

EXOSOME-BASED THERAPEUTICS AND DRUG DELIVERY SYSTEMS: ISOLATION, ENGINEERING, AND CLINICAL TRANSLATION

This review critically examines the current state of exosome-based therapeutics, focusing on isolation methods, engineering strategies, and clinical translation through early 2024, holding promise in oncology, cardiovascular disease, neurological disorders, and regenerative medicine.

Yuvaraj Nitin Sharma · 0 citations
#gene editing Review Open access Aug 2026

Nanomaterial-based drug delivery systems: From intelligent delivery to clinical translation and precision nanomedicine.

A structured translational roadmap is proposed that prioritizes biologically predictive design, fit-for-purpose safety assessment, scalable good manufacturing practice production, early regulatory alignment, and clinically meaningful benefit over unnecessary structural complexity.

Yi Li, Rui Luo, Yuxuan Li et al. · 1 citation
Review Aug 2026

Exosomes as next-generation drug carriers: Transforming cancer therapy.

This review critically examines exosome sources, isolation and characterization methodologies, cargo-loading strategies, biodistribution, pharmacokinetics, and engineering approaches together with their applications in delivering small-molecule drugs and nucleic acid-based therapeutics to overcome multidrug resistance...

Yaseera Arif, D. N. Moholkar, Raghuram Kandimalla et al. · 0 citations
Review Open access Jul 2026

Exosome Nanotechnology in Molecular Medicine: Advances, Applications and Challenges in Gene Therapy

Despite their promise, significant challenges remain, including low cargo-loading efficiency, batch heterogeneity, limited scalability and the absence of standardized manufacturing and regulatory frameworks, future research must address these barriers to accelerate the clinical translation of exosome-based therapeutics...

Elza Karabagh, Babek Alibayov, Adil Allahverdiyev · 0 citations
Review Open access Aug 2026

Extracellular Vesicles and Plant-Derived Vesicles in Cancer: From Mechanisms to Clinical Translation

The growing applicability of EVs as next-generation platforms for precision medicine, targeted drug delivery, and regenerative therapies is summarized while identifying the major obstacles that must be addressed to facilitate their successful clinical translation.

Shery Jacob, Namitha Raichel Varkey, S. Boddu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.